SCHEMBL20159211

SCHEMBL20159211

CC1(C)CC(c2ccc(N)cc2)=NN(c2ccccc2)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.40
MEN1 O00255 7/20 0.38
KMT2A Q03164 7/20 0.38
MAPT P10636 6/20 0.38
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 4/20 0.38
TDP1 Q9NUW8 3/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
PDE4A P27815 2/20 0.38
PDE4B Q07343 2/20 0.38
PDE4C Q08493 2/20 0.38
PDE4D Q08499 2/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 4/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SHMT2 P34897 1/20 0.38
RECQL P46063 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20138653 0.86 GAA (0.48) SMN1; SMN2MEN1KMT2AMAPTKDM4E
SCHEMBL20159752 0.85 SMN1; SMN2 (0.39) SMN1; SMN2MEN1KMT2AMAPTKDM4E
SCHEMBL20142920 0.79 CYP19A1 (0.45) SMN1; SMN2MEN1KMT2AMAPTKDM4E
SCHEMBL20138839 0.75 CYP19A1 (0.39) SMN1; SMN2MEN1KMT2AKDM4EALDH1A1
SCHEMBL6014950 0.75 MAPT (0.42) SMN1; SMN2MEN1KMT2AMAPTKDM4E
SCHEMBL20142933 0.74 PDE4B (0.45) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL20159203 0.72 PDE4D (0.44) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL20159426 0.72 CYP19A1 (0.38) MEN1KMT2AL3MBTL1PDE4APDE4B
SCHEMBL20138842 0.72 PDE4B (0.40) SMN1; SMN2MEN1KMT2AMAPTKDM4E
SCHEMBL20159207 0.72 MEN1 (0.41) SMN1; SMN2MEN1KMT2ALMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018086703-A1 DIHYDROPYRIDAZINONES SUBSTITUTED WITH PHENYLUREAS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-17 WO disclosed